ADVERTISEMENT
The Open
'A lot of opportunity in the conventional generics': Apotex CEO on rise of interest in generics
Jeff Watson, president and CEO of Apotex, joins BNN Bloomberg to discuss the company's next chapter and the pharma landscape in Canada.